Stock ELYM ELIEM THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Real-time Estimate Cboe BZX
Other stock markets
 10:56:12 27/06/2024 pm IST 		5-day change 1st Jan Change
7.44 USD -5.70% Intraday chart for Eliem Therapeutics, Inc. +0.26% +187.78%
12/06 Eliem Therapeutics, Inc. Appoints Aoife Brennan as Chief Executive Officer CI
12/06 Eliem Therapeutics, Inc. Announces Management Changes CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Eliem Therapeutics, Inc. Appoints Aoife Brennan as Chief Executive Officer
CI
Eliem Therapeutics, Inc. Announces Management Changes
CI
Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Kaskela Law LLC Announces Investigation of Eliem Therapeutics, Inc. (ELYM) and Encourages Investors to Contact the Firm
PR
Sector Update: Health Care Stocks Softer Late Afternoon
MT
Top Midday Gainers
MT
Sector Update: Health Care Stocks Decline Thursday Afternoon
MT
Eliem Therapeutics to Acquire Tenet Medicines; Launching Private Placement -- Eliem Shares Surge
MT
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders
BU
Top Premarket Gainers
MT
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
GL
Eliem Therapeutics, Inc. and Tenet Medicines, Inc. Announces Management and Organization Changes
CI
Eliem Therapeutics, Inc. entered into a definitive acquisition agreement to acquire Tenet Medicines, Inc.
CI
Eliem Therapeutics, Inc. announced that it expects to receive $119.955003 million in funding from RA Capital Management, L.P., Deep Track Capital, LP
CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Harpoon Therapeutics Appoints Chief Legal Officer, Chief People Officer
MT
Eliem Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Eliem Therapeutics Drops Kv7 Program, Explores Strategic Alternatives
MT
Eliem Therapeutics Plans to Explore Strategic Alternatives
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELYM Stock
  4. News Eliem Therapeutics, Inc.